A Phase 1 Study of CD38-Bispecific Antibody (XmAb18968) for Patients with Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia

被引：0
|
作者：
Murthy, Guru Subramanian Guru [1 ]
Shah, Bijal D. [2 ]
Duvall, Adam S. [3 ]
Leonard, Jessica T. [4 ]
Badar, Talha [5 ]
Yi, Cecilia Y. Arana [6 ]
Kearl, Tyce [7 ]
Baim, Arielle [8 ]
Harrington, Alexandra M. [8 ]
Szabo, Aniko [8 ]
Atallah, Ehab L. [9 ]
机构：
[1] Med Coll Wisconsin, Div Hematol Oncol, Dept Med, Milwaukee, WI USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL USA
[3] Univ Chicago, Dept Med, Chicago, IL USA
[4] Oregon Hlth & Sci Univ, Dept Hematol & Med Oncol, Portland, OR USA
[5] Mayo Clin, Jacksonville, FL USA
[6] Mayo Clin, Hematol Oncol, Scottsdale, AZ USA
[7] Med Coll Wisconsin, Div Hematol Oncol, Milwaukee, WI USA
[8] Med Coll Wisconsin, Milwaukee, WI USA
[9] Med Coll Wisconsin, Div Hematol Oncol, Milwaukee, WI USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-187468
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] A phase 1 study of CD38-bispecific antibody (XmAb18968) for patients with CD38 expressing relapsed/refractory acute myeloid leukemia and T-cell acute lymphoblastic leukemia.
    Murthy, Guru Subramanian Guru
    Kearl, Tyce
    Cui, Weigo
    Johnson, Bryon
    Hoffmeister, Karin
    Harrington, Alexandra
    Szabo, Aniko
    Badar, Talha
    Duvall, Adam
    Leonard, Jessica Taft
    Yi, Cecilia Ysabel Arana
    Baim, Arielle
    Yaghoubi, Shahriar
    Shah, Bijal D.
    Stock, Wendy
    Atallah, Ehab L.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [2] A Phase 1 Study of CD38-Bispecific Antibody (XmAb18968) for Patients with CD38 Expressing Relapsed/Refractory Acute Myeloid Leukemia
    Murthy, Guru Subramanian Guru
    Leonard, Jessica T.
    Badar, Talha
    Yi, Cecilia Y. Arana
    Duvall, Adam S.
    Shah, Bijal D.
    Baim, Arielle
    Kearl, Tyce
    Harrington, Alexandra M.
    Szabo, Aniko
    Atallah, Ehab L.
    BLOOD, 2023, 142
  • [3] A Phase 1 Study of XmAb18968, a CD3-CD38 Bispecific Antibody for the Treatment of Patients with Relapsed/Refractory Acute Leukemia and T Cell Lymphoblastic Lymphoma
    Murthy, Guru Subramanian Guru
    Kearl, Tyce J.
    Cui, Weiguo
    Johnson, Bryon
    Hoffmeister, Karin
    Szabo, Aniko
    Aoki, Kazuhiro
    Harrington, Alexandra M.
    Carlson, Karen
    Michaelis, Laura C.
    Runaas, Lyndsey
    Abedin, Sameem
    Duvall, Adam S.
    Stock, Wendy
    Shah, Bijal D.
    Leonard, Jessica
    Pratz, Keith W.
    Luger, Selina M.
    Badar, Talha
    Baim, Arielle
    Yaghoubi, Shahriar
    Atallah, Ehab L.
    BLOOD, 2021, 138
  • [4] Recent Updates on Blinatumomab: A Bispecific T-Cell Engaging Antibody in Relapsed and Refractory B-Cell Acute Lymphoblastic Leukemia
    Saleem, Tabinda
    Rafae, Abdul
    Wahab, Ahsan
    Ehsan, Hamid
    Neupane, Karun
    Rehman, Mohammad Ebad Ur
    Pachika, Pranali
    Ali, Rabia
    Ali, Sundas
    Anwer, Faiz
    BLOOD, 2021, 138
  • [5] Nelarabine for the Treatment of Patients with Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
    DeAngelo, Daniel J.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2009, 23 (05) : 1121 - +
  • [6] Dose Escalation of HLA-A2-WT1 CD3 T-Cell Bispecific Antibody in a Phase I Study in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)
    Hutchings, Martin
    Montesinos, Pau
    Santoro, Armando
    Hou, Hsin-An
    Martinez-Sanchez, Maria Pilar
    Vives, Susana
    Galimberti, Sara
    Chen, Tsai-Yun
    Frigeni, Marco
    Garciaz, Sylvain
    Salamero, Olga
    Yeh, Su-Peng
    Yee, Karen
    Schnetzler, Gabriel
    Barata, Teresa
    Simon, Silke
    Hinton, Heather
    Korfi, Koorosh
    Richard, Muriel
    Keshelava, Nino
    Subklewe, Marion
    BLOOD, 2023, 142
  • [7] NELARABINE IN CHILDREN WITH REFRACTORY AND RELAPSED T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
    Myakova, N.
    Diakonova, Y.
    Bydanov, O.
    Ponomareva, N.
    Fechina, L.
    Boychenko, E.
    Karachunsky, A.
    Shamardina, A.
    HAEMATOLOGICA, 2015, 100 : 349 - 349
  • [8] CAR T-Cell Therapy Pediatric patients with relapsed and refractory acute lymphoblastic leukemia
    Callahan, Colleen
    Baniewicz, Diane
    Ely, Beth
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2017, 21 (02) : 22 - 28
  • [9] Outcome of adults with relapsed/refractory T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma
    Samra, Bachar
    Alotaibi, Ahmad S.
    Short, Nicholas J.
    Khoury, Joseph D.
    Ravandi, Farhad
    Garris, Rebecca
    Jain, Nitin
    Konopleva, Marina
    Kantarjian, Hagop
    Jabbour, Elias
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (09) : E245 - E247
  • [10] Outcome of Adults with Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
    Samra, Bachar
    Alotaibi, Ahmad S.
    Short, Nicholas
    Khoury, Joseph
    Ravandi, Farhad
    Garris, Rebecca
    Jain, Nitin
    Konopleva, Marina
    Kantarjian, Hagop
    Jabbour, Elie
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S170 - S170
12345